Optimizing Intensive Chemotherapy Management in Secondary AML Through Academic Community Collaboration - Episode 1
Implementing Updates to AML Classification Guidelines
Panelists discuss how secondary acute myeloid leukemia (AML) presents unique challenges in diagnosis, classification, and treatment due to its complex pathogenesis and evolving classification criteria.
Video Player is loading.
Video content above is prompted by the following:
- Briefly provide an overview of secondary AML.
- What is the pathogenesis of this disease?
- What is the incidence of this disease?
- Please briefly discuss the updates to European LeukemiaNet and World Health Organization classifications for defining secondary AML.
- How have the updates to classification guidelines impacted how you diagnose and classify secondary AML patients?
Related Content:
